1 asset in Ocular Cancer
Therapeutic assets addressing Ocular Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nbm-Bmx Ocular Cancer | Novelwise Pharmaceutical Corporation | P1/2 | CCC (48) |
Therapeutic assets addressing Ocular Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nbm-Bmx Ocular Cancer | Novelwise Pharmaceutical Corporation | P1/2 | CCC (48) |